{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:36:37Z","timestamp":1791488197035,"version":"4.3.4"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2008,8,6]],"date-time":"2008-08-06T00:00:00Z","timestamp":1217980800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0002861","type":"journal-article","created":{"date-parts":[[2008,8,5]],"date-time":"2008-08-05T21:40:19Z","timestamp":1217972419000},"page":"e2861","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["A Randomised Trial of an Eight-Week, Once Weekly Primaquine Regimen to Prevent Relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan"],"prefix":"10.1371","volume":"3","clinical-trial-number":[{"clinical-trial-number":"nct00158587","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Toby","family":"Leslie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Mayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panna","family":"Erasmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kolaczinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J. M.","family":"Whitty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,8,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2001.64.97","article-title":"The neglected burden of <italic>Plasmodium vivax<\/italic> malaria.","volume":"64","author":"K Mendis","year":"2001","journal-title":"Am J Trop Med & Hyg,"},{"key":"ref2","first-page":"327","article-title":"The global distribution and population at risk of malaria: past, present, and future.","volume":"4(6)","author":"C Hay","year":"2005","journal-title":"Lancet Inf Dis,"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"984","DOI":"10.4269\/ajtmh.2007.77.984","article-title":"Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in North-eastern Indonesian Papua.","volume":"75(5)","author":"MJ Barcus","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref4","first-page":"680","article-title":"The economic and social burden of malaria.","volume":"415 (6672)","author":"J Sachs","year":"2002"},{"key":"ref5","first-page":"187","article-title":"Hypnozoites and relapses in <italic>Plasmodium vivax<\/italic> and in vivax-like malaria.","volume":"40","author":"PCC Garnham","year":"1998","journal-title":"Tropical & Geographical Medicine,"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/00034983.2001.11813694","article-title":"Malaria epidemiology and control in refugee camps and complex emergencies.","volume":"95","author":"M Rowland","year":"2001","journal-title":"Ann Trop Med Para,"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0035-9203(03)00041-5","article-title":"Compliance with 14-day primaquine therapy for radical cure of <italic>vivax<\/italic> malaria \u2013 a randomized placebo-controlled trial comparing unsupervised with supervised treatment.","volume":"98(3)","author":"T Leslie","year":"2004","journal-title":"Tran R Soc Trop Med Hyg."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0035-9203(02)90331-7","article-title":"Anopheline vectors and malaria transmission in eastern Afghanistan.","volume":"96(6)","author":"M Rowland","year":"2002","journal-title":"Tran R Soc Trop Med Hyg."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0035-9203(95)90661-4","article-title":"Prevalence and clinical presentation of glucose-6-phosphate dehydrogenase deficiency in Pakistani Pathan and refugee communities in Pakistan; implications for the use of primaquine in regional malaria control programs.","volume":"89","author":"MJ Bouma","year":"1995","journal-title":"Tran R Soc Trop Med Hyg,"},{"key":"ref10","first-page":"137","article-title":"Frequency of glucose-6-phosphate hydrogenase deficiency in some ethnic groups of Pakistan.","volume":"15(3)","author":"N Ali","year":"2005","journal-title":"J Coll Physicians Surg Pak."},{"key":"ref11","first-page":"64","article-title":"Guidelines for the treatment of malaria.","year":"2006"},{"key":"ref12","article-title":"Practical Chemotherapy of Malaria.","year":"1990"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0035-9203(99)90081-0","article-title":"Randomised controlled trial of 5 and 14 day primaquine therapy against relapses of malaria in an Afghan refugee settlement in Pakistan.","volume":"93","author":"M Rowland","year":"1999","journal-title":"Tran R Soc Trop Med Hyg."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/00034983.1999.11813486","article-title":"Efficacies of 5 and 14 day primaquine regimens in the prevention of relapses in <italic>Plasmodium vivax<\/italic> infections.","volume":"93","author":"NJ Gogtay","year":"1999","journal-title":"Ann Trop Med Parasitol"},{"key":"ref15","article-title":"Primaquine for preventing relapses in people with Plasmodium vivax malaria. Cochrane Database of Systematic Reviews 2007, Issue 1.","author":"GNL Galappaththy","year":"2007"},{"key":"ref16","first-page":"621","article-title":"Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of Chesson strain of <italic>Plasmodium vivax<\/italic> by intermittent regimens of drug administration.","volume":"22","author":"AS Alving","year":"1960","journal-title":"Bull WHO"},{"key":"ref17","first-page":"303","article-title":"The Haemolytic effect of various regimens with primaquine and chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism.","volume":"36","author":"GJ Brewer","year":"1967"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3565(24)29564-1","article-title":"Primaquine induced haemolytic anaemia: Formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.","volume":"297(2)","author":"LJC Bolchoz","year":"2001","journal-title":"J Pharmacol Exp Ther."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4269\/ajtmh.2007.76.201","article-title":"A rare glimpse at the efficacy of primaquine.","volume":"76(2)","author":"JK Baird","year":"2007","journal-title":"Am J Trop Med Hyg."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/0006-2952(88)90263-8","article-title":"Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine.","volume":"37(13)","author":"KA Fletcher","year":"1988","journal-title":"Biochem Pharmacol."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2125.1985.tb02709.x","article-title":"Pharmacokinetics of Primaquine in man I. Studies of the absolute bioavailability and effects of dose size.","volume":"19","author":"GW Mihaly","year":"1985","journal-title":"Br. J. Clin. Pharmac."},{"key":"ref22","first-page":"391","article-title":"Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug.","volume":"59(3)","author":"DF Clyde","year":"1981","journal-title":"Bull WHO."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4269\/ajtmh.2007.76.203","article-title":"Regional differences in the response of <italic>Plasmodium vivax<\/italic> malaria to primaquine as anti-relapse therapy.","volume":"76(2)","author":"JL Goller","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/512241","article-title":"Relapse of <italic>Plasmodium vivax<\/italic> infection usually result from the activation of heterologous hypnozoites.","volume":"195","author":"M Imwong","year":"2007","journal-title":"JID."},{"key":"ref25","article-title":"Management of vivax malaria with low sensitivity to primaquine.","author":"KM Ajdukiewicz","year":"2006","journal-title":"J Infect. Abstract. E Publication. 2006."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/00034983.1997.11813222","article-title":"Primaquine-tolerant vivax malaria in Thailand.","volume":"91","author":"S Looareesuwan","year":"1997","journal-title":"Ann Trop Med Parasitol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.297.20.2201","article-title":"Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of <italic>Plasmodium vivax<\/italic> malaria in Afghanistan and Pakistan: A randomised control trial.","volume":"297(20)","author":"T Leslie","year":"2007","journal-title":"JAMA."},{"key":"ref28","first-page":"e1089","article-title":"Chloroquine resistant <italic>Plasmodium vivax<\/italic>: <italic>in vitro<\/italic> characteristics and association with molecular polymorphisms.","volume":"10","author":"R Suwanarusk","year":"2007"},{"key":"ref29","first-page":"736","article-title":"High-dose Primaquine Regimens against Relapse of <italic>Plasmodium vivax<\/italic> Malaria.","volume":"78(5)","author":"S Krudsood","year":"2008"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-3156.2004.01364.x","article-title":"How do patients use antimalarial drugs? A review of the evidence.","volume":"10(2)","author":"S Yeung","year":"2005","journal-title":"Top Med Int Health."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.318.5856.1544","article-title":"Did they really say\u2026 eradication?","volume":"318(5856)","author":"L Roberts","year":"2007","journal-title":"Science."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0002861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T10:01:11Z","timestamp":1738317671000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0002861"}},"subtitle":[],"editor":[{"given":"Fran\u00e7ois","family":"Nosten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,8,6]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2008,8,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0002861","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,6]]}}}